Mar 12, 2024 / 07:05PM GMT
Carter Lewis Gould - Barclays Bank PLC, Research Division - Senior Analyst
Good afternoon and welcome to Day 1 of the Barclays Global Healthcare Conference. My name is Carter Gould, covering U.S. biopharma. I'm pleased to welcome Merck to the stage. Merck is one of our top picks to start the year. And it's been a good year for Merck.
Joining us from the company, Jannie Oosthuizen, President, Human Health U.S.; as well as Peter Griffith (sic) from the IR team. Welcome, Merck. Thank you very much for joining us.
Maybe before we get to start. We can just jump into Q&A. If you want to make some opening comments. But I think we were just going to jump in as we discussed, yes?
Johannes J. Oosthuizen - Merck & Co., Inc. - Senior VP & President Merck U.S. Human Health
Well, I mean, I can just make a few comments. But thank you for having us, Carter. It's good to be back. You said it, I think it's an exciting time to be at Merck. We're benefiting from strong execution across our clinical program, across our commercial organization. And we
Merck & Co Inc at Barclays Global Healthcare Conference Transcript
Mar 25, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers